According to reports, a cause for concern is that 51 of the cases involve infants under one year of age, while 553 are among children under 18.

Valneva SE offers exposure to a robust travel vaccine portfolio that includes Ixiaro, Dukoral, and Ixchiq. Read what ...

Chandigarh: Amid a steady rise in dengue and chikungunya cases across the state, the Punjab health department directed all ...

Valneva (VALN) stock slips as the EU drug regulator suspends chikungunya vaccine for adults 65+ over safety concerns. Read ...

The decision was taken following a plenary meeting of the Pharmacovigilance Risk Assessment Committee (PRAC) on May 5, 2025 and is based on reports of 17 SAEs worldwide (including two deaths) in ...

The European Union's health regulator said on Wednesday it was reviewing French drugmaker Valneva's chikungunya vaccine after ...

Recommendations for the use of chikungunya vaccine were recently discussed at a meeting of the Advisory Committee on Immunization Practices.

Releases of sterile male mosquitoes in L.A. County drove down the pest population, studies found. But homeowners would need ...

Maharashtra reported a significant rise in Chikungunya cases, increasing from 473 in early 2024 to 658 by April 2025. While other vector-borne diseases like malaria and dengue show a downward trend, ...

As the rainy season and school term begin in Thailand, AXA Insurance Thailand is highlighting its Tropical Disease Insurance ...

As safety flags hang over Valneva’s chikungunya vaccine in the U.S. and beyond, French authorities are clamping down on the shot’s use in older adults. | France’s public health agency has temporarily ...

Shares in Valneva plunged after the company said France's health authorities suspended the use of its chikungunya vaccine, Ixchiq, for people aged 65 and older, raising concerns about the vaccine's ...